Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by James Andrea S.. Director active across 2 companies, notably OncoCyte Corp. Cumulatively, 6 filings have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €327k. Activity tracked since 2 October 2024. The latest transaction was disclosed on 31 October 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
James Andrea S. is a declarant linked to Insight Molecular Diagnostics Inc. and OncoCyte Corp, where he is Chief Financial Officer. The 6 filings in the recent sample cover the period from 2024-10-04 to 2026-03-30, with EUR 326642 of buys and EUR 0 of sells, and the most frequent transaction nature is option exercise.